Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritisTsutomu Takeuchi, Takayoshi Koike, Shigeko Inokuma et al.|Annals of the Rheumatic Diseases|2007Cited by 413